17081-Myelomas-NA-1286

Myelomas

C16038: An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (Phase IV)

  • Details

ClinicalTrials.gov ID: NCT03173092
Diagnosis Type: NA
USOR Number: 17081

  • Address

1845 W Orange Grove, Bldg 2
Tucson, AZ 85704
P: (520) 531-8967

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.